A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104). Ho AL, Foster NR, Deraje Vasudeva S, Katabi N, et al. Cancer 2024;130:702-712.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ho AL, Foster NR, Deraje Vasudeva S, Katabi N, et al. A phase 2 study of MK-2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104). Cancer 2024;130:702-712.
PMID: 37947157